Cytek Biosciences (CTKB) Change in Acquisitions & Divestments (2023 - 2026)

Cytek Biosciences has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $70.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed 0.4% year-over-year to $70.7 million; the trailing twelve-month figure through Mar 2026 stood at $292.5 million (up 51.21% YoY), and the FY2025 full-year result was $292.2 million, up 49.85% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $70.7 million, down from $76.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $79.2 million in Q3 2025, with the low at $10.0 million in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $57.5 million across 4 years, with a median of $67.2 million in 2023.
• The largest YoY upside for Change in Acquisitions & Divestments was 300.0% in 2024 against a maximum downside of 44.12% in 2024.
• Cytek Biosciences' Change in Acquisitions & Divestments stood at $54.0 million in 2023, then fell by 16.67% to $45.0 million in 2024, then surged by 69.12% to $76.1 million in 2025, then declined by 7.08% to $70.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $70.7 million (Q1 2026), $76.1 million (Q4 2025), and $79.2 million (Q3 2025), per Business Quant data.